Summary of Significant Accounting Policies (Details 3) (USD $) In Thousands, unless otherwise specified	3 Months Ended												12 Months Ended
	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2011	Sep. 30, 2011	Jun. 30, 2014 item	Jun. 30, 2013	Jun. 30, 2012
Segment information
Number of reportable segments													1
Medical Indication Information
Total	$ 80,619	$ 79,997	$ 67,326	$ 45,829	$ 40,174	$ 39,022	$ 36,564	$ 35,294	$ 35,690	$ 30,688	$ 27,734	$ 28,878	$ 273,771	$ 151,054	$ 122,990
Antibiotic
Medical Indication Information
Total													13,572	9,167	6,724
Cardiovascular
Medical Indication Information
Total													62,121	25,876	18,142
Gallstone
Medical Indication Information
Total													6,578	6,114	5,991
Glaucoma
Medical Indication Information
Total													11,987	6,410	4,252
Gout
Medical Indication Information
Total													10,822	5,092	484
Migraine
Medical Indication Information
Total													14,527	5,418	5,971
Obesity
Medical Indication Information
Total													4,032	4,721	3,755
Pain Management
Medical Indication Information
Total													27,174	21,232	20,870
Thyroid Deficiency
Medical Indication Information
Total													102,248	57,978	50,849
Other
Medical Indication Information
Total													$ 20,710	$ 9,046	$ 5,952